# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-047373
Filing Date
2024-11-22
Accepted
2024-11-22 16:27:47
Documents
7
Period of Report
2024-11-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 198564
2 |  | formdef14a_001.jpg | GRAPHIC | 6090
3 |  | formdef14a_002.jpg | GRAPHIC | 1619
4 |  | sign_001.jpg | GRAPHIC | 2038
5 |  | sign_002.jpg | GRAPHIC | 2038
6 |  | proxy_001.jpg | GRAPHIC | 311700
7 |  | proxy_002.jpg | GRAPHIC | 427463
| Complete submission text file | 0001493152-24-047373.txt |  | 1234635

Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41463 | Film No.: 241490135
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)